These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 18489579

  • 1. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T, Seeman P, Kuroiwa M, Nishi A.
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [Abstract] [Full Text] [Related]

  • 2. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T, Kuroiwa M, Hamamura M, Yabuuchi K, Shimazoe T, Watanabe S, Nishi A, Yamamoto T.
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [Abstract] [Full Text] [Related]

  • 3. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 4. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 5. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 6. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 7. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L, Jurajda M, Sulcova A.
    Neuro Endocrinol Lett; 2012 Jun; 33(4):446-52. PubMed ID: 22936253
    [Abstract] [Full Text] [Related]

  • 8. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Thomas LI.
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [Abstract] [Full Text] [Related]

  • 9. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 10. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D, Snyder SE, Watts VJ, Mailman RB, Nichols DE.
    J Med Chem; 1996 Jan 19; 39(2):549-55. PubMed ID: 8558526
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P.
    Synapse; 2009 Mar 19; 63(3):186-92. PubMed ID: 19086090
    [Abstract] [Full Text] [Related]

  • 12. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM, Kreipke CW, Walker PD.
    Neuroscience; 2006 Mar 19; 137(2):505-17. PubMed ID: 16289829
    [Abstract] [Full Text] [Related]

  • 13. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA, Mitrovic I, Battaglia G, Napier TC.
    Exp Neurol; 2004 Apr 19; 186(2):145-57. PubMed ID: 15026253
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ.
    J Pharmacol Exp Ther; 2001 Jul 19; 298(1):129-40. PubMed ID: 11408534
    [Abstract] [Full Text] [Related]

  • 15. Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
    Cory-Slechta DA, Pokora MJ, Fox RA, O'Mara DJ.
    Neurotoxicology; 1996 Jul 19; 17(2):445-57. PubMed ID: 8856740
    [Abstract] [Full Text] [Related]

  • 16. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
    Wang JQ, McGinty JF.
    J Pharmacol Exp Ther; 1997 May 19; 281(2):972-82. PubMed ID: 9152408
    [Abstract] [Full Text] [Related]

  • 17. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B, Frenois F, Zold CL, Chetrit J, Murer MG, Gonon F.
    Neurobiol Dis; 2009 Sep 19; 35(3):376-84. PubMed ID: 19501163
    [Abstract] [Full Text] [Related]

  • 18. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A, Eller M, Herm L, Rinken A, Harro J.
    Brain Res; 2007 Feb 02; 1131(1):138-48. PubMed ID: 17156751
    [Abstract] [Full Text] [Related]

  • 19. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA.
    J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114
    [Abstract] [Full Text] [Related]

  • 20. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C, André VM, Yamazaki I, Wu N, Kleiman-Weiner M, Levine MS.
    Eur J Neurosci; 2008 Feb 22; 27(3):671-82. PubMed ID: 18279319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.